Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case–control study

BACKGROUND: Schizophrenia is associated with increased cardiovascular morbidity and mortality. Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of the nitric oxide synthase, and the L-arginine:ADMA ratio are markers of endothelial dysfunction that predict mortality and adverse outcome in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorgensen, Anders, Knorr, Ulla, Soendergaard, Mia Greisen, Lykkesfeldt, Jens, Fink-Jensen, Anders, Poulsen, Henrik Enghusen, Jorgensen, Martin Balslev, Olsen, Niels Vidiendal, Staalsø, Jonatan Myrup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394403/
https://www.ncbi.nlm.nih.gov/pubmed/25880260
http://dx.doi.org/10.1186/s12888-015-0455-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394403/
https://www.ncbi.nlm.nih.gov/pubmed/25880260
http://dx.doi.org/10.1186/s12888-015-0455-4

Ejemplares similares